The neuropathy literature on fisetin is small, about ten focused papers, but it is more interesting than its size suggests for two reasons. The models used are closer to real clinical problems than most fisetin research, covering diabetic nerve pain and chemotherapy-induced neuropathy rather than an abstract disease model. And it contains the clearest drug interaction signal anywhere in the fisetin literature, one that points in a direction most supplement pages never mention.
Key Takeaways
- In diabetic mice, chronic oral fisetin both reversed established mechanical allodynia and thermal hyperalgesia and prevented them from developing when given early, without changing blood sugar at all.[1]
- That analgesic effect was abolished by blocking spinal GABA-A receptors and by adding a reactive oxygen species donor, placing the mechanism on antioxidant activity feeding into spinal GABA-A signalling.[1]
- In a 2025 rat model of cisplatin-induced peripheral neuropathy, fisetin improved nerve conduction velocity, preserved myelin, and normalised GPX4 and NF-κB. Notably, 10 mg/kg outperformed 20 mg/kg.[2]
- A dose of fisetin too low to relieve pain on its own significantly increased both the size and the duration of the effect of gabapentin and pregabalin.[3]
- Fisetin also enhanced morphine and oxycodone analgesia in a nerve injury model, though it was delivered directly into the spinal canal rather than swallowed.[4]
- If you take gabapentin, pregabalin, or an opioid, this is a conversation to have with your prescriber before adding fisetin, not after.
Diabetic nerve pain: the strongest single study
Zhao and colleagues induced type 1 diabetes in mice, then used von Frey filaments and the Hargreaves test to measure mechanical allodynia and thermal hyperalgesia, the two hallmark symptoms of painful diabetic neuropathy. Chronic fisetin did two separate things: it reduced symptoms that had already developed, and at lower doses it stopped them developing in the first place.[1]
The detail that makes this study worth reading is that fisetin did not lower blood glucose. The mice stayed hyperglycemic. Whatever fisetin was doing, it was acting on the nerve pain directly rather than by treating the diabetes underneath it, which is a cleaner result than the alternative. Measurement confirmed reduced oxidative stress in the spinal cord, dorsal root ganglion and sciatic nerve.
They then ran two mechanism tests. Co-treating with a reactive oxygen species donor abolished the pain relief; a ROS scavenger amplified it. And acutely blocking spinal GABA-A receptors with bicuculline wiped the effect out completely. That is a specific mechanism, not a vague antioxidant hand-wave.
Chemotherapy-induced neuropathy
Cisplatin-induced peripheral neuropathy is a common and often permanent side effect of chemotherapy with no good treatment. A 2025 rat study tested fisetin at 10 and 20 mg/kg against it and measured more than behaviour: nerve conduction velocity electrophysiologically, myelin basic protein, GFAP, NF-κB and GPX4 expression, and sciatic nerve structure by confocal microscopy.[2]
Fisetin improved motor coordination, sensory thresholds and conduction velocity, preserved myelin integrity, and restored the oxidative and inflammatory markers. The result the authors flagged specifically was that 10 mg/kg worked better than 20 mg/kg. Higher was not better, which is a pattern that shows up often enough with flavonoids to be worth remembering when reading dosage advice.
If you are on chemotherapy, note that this overlaps with a separate and more important question about taking fisetin during chemotherapy, where timing and enzyme interactions matter and the answer is not simply yes.
The interaction finding
This is the part that changes what you should do rather than just what you know. Karabacak and colleagues ran a chronic constriction nerve injury model in rats and tested fisetin at 5, 10 and 20 mg/kg alone, then in combination with gabapentin at 50 mg/kg and pregabalin at 15 mg/kg. They deliberately picked 5 mg/kg for the combinations, a dose that produced no significant pain relief by itself.[3]
Combined with gabapentin or pregabalin, that inactive dose produced significantly greater pain relief than either drug alone, and the effect lasted longer. The authors framed this positively, as a way to use lower doses of drugs with meaningful side effects. Read from the perspective of somebody already taking gabapentin at a stable dose, it says something different: adding fisetin may not leave that dose behaving the way it did before.
A separate group found the same direction with opioids. In a chronic constriction injury model, fisetin reduced tactile and thermal hypersensitivity on its own and increased the effect of morphine and oxycodone.[4] One important caveat: in that study fisetin was given intrathecally, injected directly into the spinal canal, which bypasses fisetin’s absorption problem entirely and is not comparable to swallowing a capsule.
How much of this reaches a person taking capsules
Honestly, unclear, and probably less than the numbers suggest. The oral studies used 5 to 20 mg/kg in rodents given daily for weeks. Rodents also metabolise flavonoids differently from humans, and fisetin’s oral absorption is poor enough that several research groups have abandoned plain fisetin for formulated versions.
What the evidence does support is a plausible mechanism, a consistent direction across two different neuropathy causes, and a specific spinal target. What it does not support is fisetin as a treatment for neuropathy. There is no human trial in any form of nerve pain.
The practical version
If you have neuropathy and take nothing for it, this literature is a reason for mild curiosity and nothing more. If you have neuropathy and take gabapentin, pregabalin, or an opioid, the interaction signal here is the most actionable finding on this page, and it argues for asking your prescriber first. See our drug interactions page for the broader list.
Frequently Asked Questions
Does fisetin help nerve pain?
In animal models, yes. Chronic oral fisetin reduced mechanical allodynia and thermal hyperalgesia in diabetic mice without changing blood sugar, and improved nerve conduction velocity in rats with cisplatin-induced neuropathy. The mechanism involves antioxidant activity feeding into spinal GABA-A receptors. No human trial exists.
Can I take fisetin with gabapentin or pregabalin?
Ask your prescriber first. In a rat nerve injury model, a dose of fisetin too low to relieve pain by itself significantly increased both the strength and the duration of gabapentin and pregabalin effects. That means adding fisetin may change how your existing dose behaves.
Does fisetin affect opioid painkillers?
In one mouse study of neuropathic pain, fisetin enhanced the analgesia produced by morphine and oxycodone. Fisetin was administered intrathecally in that study, directly into the spinal canal, so it does not translate directly to oral supplements, but it is a reason to raise the combination with your prescriber.
References
- Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors. Pharmacol Res (2015). PMID 26520392
- Fisetin mitigates cisplatin-induced peripheral neuropathy: a behavioral and immunohistochemical study. Mol Biol Rep (2025). PMID 40167901
- Use of quercetin and fisetin flavonoids in combination with pregabalin and gabapentin in the treatment of neuropathic pain. J Pharm Pharmacol (2024). PMID 38588462
- Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain. Int J Mol Sci (2023). PMID 37240346
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.